News

Filter

Current filters:

None

19 to 28 of 97916 results

Pharma CEO salaries and performance pay “is not politicians’ business,” says Polyplus chief

Pharma CEO salaries and performance pay “is not politicians’ business,” says Polyplus chief

04-03-2015

The political establishment needs to concentrate on cleaning up its own act and concentrating on their…

ManagementPharmaceuticalPoliticsPolyplusSanofi

US FDA warns on over-prescribing of testosterone products

US FDA warns on over-prescribing of testosterone products

04-03-2015

The US Food and Drug Administration is requiring that the manufacturers of all approved prescription…

AbbVieAndroGelAxironEli LillyMen's HealthPharmaceuticalRegulationUSA

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

04-03-2015

Analysts at Morningstar Equity Research see significantly more opportunity than the overall market for…

AstraZenecaBiotechnologyBristol-Myers SquibbMarkets & MarketingMerck & CoOncologyOpdivoResearchRoche

CASI Pharmaceuticals appoints Rong Chen as chief medical officer

CASI Pharmaceuticals appoints Rong Chen as chief medical officer

04-03-2015

Oncology biopharma company CASI Pharmaceuticals has appointed Rong Chen as chief medical officer.

BoardroomCASICASI PharmaceuticalsGlaxoSmithKlinePharmaceutical

Patent reform bill to protect innovation, confront abuse introduced in USA

Patent reform bill to protect innovation, confront abuse introduced in USA

04-03-2015

US Senators Chris Coons (Democrat, Delaware) and Dick Durbin (Democrat, Illinois), members of the Senate…

LegalPatentsPharmaceuticalPoliticsUSA

Takeda promotes Christophe Weber to chief executive

Takeda promotes Christophe Weber to chief executive

04-03-2015

Japan’s largest drugmaker Takeda Pharmaceutical has promoted Christophe Weber from representative director,…

BoardroomJapanPharmaceuticalTakeda PharmaTakeda Pharmaceutical

Orexigen shares jump on Contrave trial interim data but FDA orders more cardio studies

Orexigen shares jump on Contrave trial interim data but FDA orders more cardio studies

04-03-2015

The US Food and Drug Administration has said it is “disappointed” by Orexigen Therapeutics’ decision…

ContraveMetabolicsNeurologicalOrexigen TherapeuticsPharmaceuticalRegulationUSA

FDA formally accepts Actelion's NDA for Uptravi

FDA formally accepts Actelion's NDA for Uptravi

04-03-2015

Switzerland-based Actelion, Europe’s largest biotech company, says that the US Food and Drug Administration…

ActelionBiotechnologyRegulationRespiratory and PulmonaryselexipagUptraviUSA

19 to 28 of 97916 results

Back to top